Company Overview
| Stock Name | Sinohealth Tech |
|---|---|
| Stock Code | 02361 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們主要提供健康洞察解決方案,以解決醫療產品製造商客戶的銷售及營銷需求。該等解決方案主要基於我們的零售數據,而零售數據佔我們健康大數據的大部分。我們在醫療產品及渠道分部處於領先地位。 |
| Listing Date | 2022-07-12 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省廣州市南沙區黃閣鎮望江二街5號1111房 |
| Business Address (Hong Kong) | 香港灣仔皇后大道東248號大新金融中心40樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | ir.sinohealth.cn |
| Share Registrar | 宝德隆 |
| Registrar Contact | (852)2153 1688 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 5.36 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | 500 shares |
| Entry Threshold | HK$ 2,680 |
| Par Value | To be extracted |
| Offer Period | 2022-06-28 to 2022-07-05 |
| Global Offering Shares | 75,000,000 shares |
| HK Public Offer Shares (Initial) | 7,500,000 shares (10.0%) |
| Public Offer Lots (Initial) | 15,000lots (Pool A7,500lots,Pool B7,500lots) |
| International Placing Shares (Initial) | 67,500,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 450,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 32.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 402,000,000 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 2,680 |
| 2 lots | 1,000 | HK$ 5,360 |
| 3 lots | 1,500 | HK$ 8,040 |
| 4 lots | 2,000 | HK$ 10,720 |
| 5 lots | 2,500 | HK$ 13,400 |
| 6 lots | 3,000 | HK$ 16,080 |
| 7 lots | 3,500 | HK$ 18,760 |
| 8 lots | 4,000 | HK$ 21,440 |
| 9 lots | 4,500 | HK$ 24,120 |
| 10 lots | 5,000 | HK$ 26,800 |
| 15 lots | 7,500 | HK$ 40,200 |
| 20 lots | 10,000 | HK$ 53,600 |
| 25 lots | 12,500 | HK$ 67,000 |
| 30 lots | 15,000 | HK$ 80,400 |
| 40 lots | 20,000 | HK$ 107,200 |
| 50 lots | 25,000 | HK$ 134,000 |
| 75 lots | 37,500 | HK$ 201,000 |
| 100 lots | 50,000 | HK$ 268,000 |
| 150 lots | 75,000 | HK$ 402,000 |
| 200 lots | 100,000 | HK$ 536,000 |
| 250 lots | 125,000 | HK$ 670,000 |
| 300 lots | 150,000 | HK$ 804,000 |
| 400 lots | 200,000 | HK$ 1,072,000 |
| 1,000 lots | 500,000 | HK$ 2,680,000 |
| 1,500 lots | 750,000 | HK$ 4,020,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 1.73B |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +461% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 2,412,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣72.0百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue | 177,750 | 202,073 | 324,166 |
| Cost of sales | -71,654 | -71,867 | -131,527 |
| Gross profit | 106,096 | 130,206 | 192,639 |
| Other income and gains, net | 15,662 | 19,026 | 29,537 |
| Selling and distribution expenses | -10,691 | -14,833 | -24,786 |
| Administrative expenses | -12,780 | -16,585 | -44,163 |
| Net finance costs | -576 | -1,222 | -532 |
| Share of associates and JVs | 0 | 0 | -416 |
| Profit before tax | 67,115 | 76,072 | 95,529 |
| Income tax expense | -12,736 | -10,743 | -23,551 |
| Profit for the year | 54,379 | 65,329 | 71,978 |
| Profit attributable to owners | 56,089 | 67,926 | 78,813 |
Balance Sheet
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Cash and cash equivalents | 220,635 | 115,778 | 33,955 |
| Trade and bills receivables | 19,536 | 28,712 | 81,866 |
| Inventories | 599 | 573 | 680 |
| Total current assets | 423,462 | 507,161 | 500,414 |
| Total assets | 440,851 | 542,207 | 517,023 |
| Total current liabilities | 37,596 | 55,282 | 96,138 |
| Total liabilities | 44,925 | 77,582 | 101,112 |
| Total equity | 395,926 | 464,625 | 415,911 |
| Equity attributable to owners | 394,739 | 462,665 | 416,858 |
Cash Flow Statement
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Net cash from operating activities | 57,844 | 61,598 | 60,020 |
| Net cash from investing activities | -180,558 | -166,559 | -9,469 |
| Net cash from financing activities | -4,053 | 103 | -132,410 |
| Net increase in cash | -126,767 | -104,858 | -81,859 |
| Depreciation of PP&E | 1,601 | 1,934 | 2,083 |
| Depreciation of right-of-use assets | 3,827 | 5,519 | 4,849 |
| Amortisation of intangible assets | 414 | 430 | 420 |
| Purchase of PP&E | -4,157 | -933 | -1,878 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 5.36 |
|---|---|
| First Day Open | HK$ 4.74 |
| First Day Change | -8.21% |
| First Day Volume | 21540500.0 |
| First Day Turnover | 111142000.0 |
| Use of Proceeds | 1、約50.8%,或170.4百萬港元將主要用于升級及提升我們的SaaS產品(專注于智慧決策云、智慧零售云及智慧醫療云)以及其營銷及推廣;
2、約49.2%,即165.0百萬港元將主要用于對我們的技術及數據倉庫進行進一步研發。 |
Underwriting Syndicate
Sole Sponsor (1)
BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669
Overall Coordinators (3)
Joint Bookrunners (8)
BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669
建银国际金融有限公司 CE AJO225
ORIENT SECURITIES (HONG KONG) LIMITED CE AVD362
海通国际证券有限公司 CE AAF806
UOB KAY HIAN (HONG KONG) LIMITED CE AAW261
国泰君安证券(香港)有限公司 CE ABY236
Eddid Securities and Futures Limited CE BHT550
ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855
Joint Lead Managers (12)
BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669
建银国际金融有限公司 CE AJO225
ORIENT SECURITIES (HONG KONG) LIMITED CE AVD362
海通国际证券有限公司 CE AAF806
UOB KAY HIAN (HONG KONG) LIMITED CE AAW261
国泰君安证券(香港)有限公司 CE ABY236
Eddid Securities and Futures Limited CE BHT550
ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855
富途证券国际(香港)有限公司 CE AZT137
AUSTRAX SECURITIES LIMITED CE BHV052
Fosun International Securities Limited CE AAF432
Livermore Holdings Limited CE BJN764
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Lun’s Family Holdings Limited | 15,535,960 HKD | — | 3.86% | — | 6 months | 2023-01-12 |
| 2 | 百洋健康产业国际商贸有限公司 | 29,699,760 HKD | — | 7.39% | — | 6 months | 2023-01-12 |
| 3 | 广东康石壹号私募股权投资合伙企业(有限合伙) | 38,661,680 HKD | — | 9.62% | — | 6 months | 2023-01-12 |
| 4 | 郑靖杰 | 46,865,160 HKD | — | 11.66% | — | 6 months | 2023-01-12 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 吳鬱抒 | — |
| Company Secretary | 易旭暉 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 吳鬱抒及王莉芳通過盈連BVI、WLF BVI、Rikan LLP合計持有約59.775%;李捍雄及吳美容通過Montesy Capital BVI持有約15.225%;俞熔通過上海天億BVI及中衛騰雲BVI持有約7.9412% |
|---|




